ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
3 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
1 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
6 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
6
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
1 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
4 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
3 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
3
|
|
Charts
|
BRN |
Re:
Chart
|
|
wilzy123
|
20K |
8.0M |
5 |
13/02/22 |
13/02/22 |
Charts
|
20K
|
8.0M
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
4 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
RNU Graphite |
Re:
General Discussions
|
|
wilzy123
|
29K |
14M |
10 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
29K
|
14M
|
10
|
|
Charts
|
BRN |
Re:
Chart
|
|
wilzy123
|
20K |
8.0M |
3 |
13/02/22 |
13/02/22 |
Charts
|
20K
|
8.0M
|
3
|
|
Charts
|
BRN |
Re:
Chart
|
|
wilzy123
|
20K |
8.0M |
1 |
13/02/22 |
13/02/22 |
Charts
|
20K
|
8.0M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Why I've sold all my BRN... and all my other Stocks
|
|
wilzy123
|
1.3K |
668K |
24 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
1.3K
|
668K
|
24
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
3 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
11 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
11
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
5 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
7 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
9 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
10 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
wilzy123
|
185 |
88K |
9 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
88K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
26 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
26
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
9 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
0 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
wilzy123
|
185 |
88K |
25 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
88K
|
25
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
wilzy123
|
185 |
88K |
34 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
88K
|
34
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
wilzy123
|
10K |
4.7M |
12 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
12
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
wilzy123
|
185 |
88K |
52 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
88K
|
52
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
wilzy123
|
185 |
88K |
115 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
88K
|
115
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
22 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
22
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
11 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
11
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
wilzy123
|
179 |
50K |
8 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
wilzy123
|
179 |
50K |
12 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
12
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
wilzy123
|
179 |
50K |
6 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
6 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
21 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
21
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
962
|
291K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
wilzy123
|
179 |
50K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
7
|
|
Charts
|
BRN |
Re:
Chart
|
|
wilzy123
|
20K |
8.0M |
20 |
02/02/22 |
02/02/22 |
Charts
|
20K
|
8.0M
|
20
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
wilzy123
|
962 |
291K |
20 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
962
|
291K
|
20
|
|